市場調査レポート

商品コード

1734890

オメガ3市場の2032年までの予測：タイプ別、ソース別、用途別、地域別の世界分析

Omega-3 Market Forecasts to 2032 - Global Analysis By Type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), Alpha-linolenic Acid (ALA) and Other Types), Source (Marine Source, Plant Source and Other Sources), Application and By Geography

出版日: 2025年05月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 607,352円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 768,337円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 929,322円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,097,625円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.35円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界のオメガ3市場は2025年に107億6,000万米ドルを占め、予測期間中のCAGRは16.7％で成長し、2032年までには317億2,000万米ドルに達すると予想されています。

オメガ3脂肪酸は、多くの身体機能をサポートする必須栄養素であり、心臓、脳、目の健康に対する利点は十分に文書化されています。亜麻仁やクルミのような植物源や、サケやサバのような脂肪分の多い魚は、これらの多価不飽和脂肪酸の一般的な供給源です。オメガ3脂肪酸は人体で効率よく合成できないため、定期的な摂取が必要です。さらに、オメガ3脂肪酸は心臓血管の健康をサポートし、認知機能を高め、炎症を抑え、関節炎や心臓病などの慢性疾患のリスクを軽減する可能性があることが研究で実証されています。

米国心臓協会（AHA）によると、オメガ3脂肪酸は心臓血管の健康に重要な役割を果たしています。AHAは、これらの有益な栄養素を摂取するために、成人にはサケ、サバ、イワシなどの脂肪分の多い魚を週に少なくとも2皿摂取することを推奨しています。AHAは、中性脂肪値が高めの人に対し、医師の指導の下、EPAとDHAを合わせて1日2グラムから4グラム摂取することで、中性脂肪を20％から40％効果的に低下させることを勧めています。

健康に関する知識の増加

オメガ3脂肪酸、特にEPAとDHAは、心臓の健康をサポートし、炎症を抑え、脳の発達を助け、視力を改善する役割について徹底的に研究されてきました。公衆衛生キャンペーンや米国心臓協会のような医療機関からの支持は、長期的な健康維持におけるオメガ3脂肪酸の役割をさらに強固なものにしています。世界中の消費者の健康意識が高まるにつれ、予防ヘルスケアや栄養ソリューションに対する需要が高まっています。さらに、先を見越した健康管理へのシフトが、オメガ3系サプリメントや強化食品を日常生活に取り入れる人々を後押ししています。

高い生産コストと最終製品コスト

高品質のオメガ3脂肪酸、特にEPAとDHAを海洋資源から抽出、精製、安定化することは、高価な作業です。超臨界CO2抽出と分子蒸留は、効率的だがコストのかかる2つの技術です。また、規制された漁業で獲れた魚や、管理された条件下で栽培された藻類も、生産コストを上昇させます。オメガ3を強化した製品やサプリメントは、他の栄養補助食品と比較すると比較的高価ですが、これはこうしたコストが消費者に転嫁されることが多いためです。さらに、特に消費者が価格に敏感な新興国では、この高価格帯によって大衆市場への浸透が制限される可能性があります。

植物や藻類由来のオメガ3へのニーズの高まり

菜食主義や植物ベースの食生活が世界中で人気を集め続けていることから、動物性でないオメガ3源への需要が高まっています。ベジタリアン、菜食主義者、環境に配慮する消費者は、魚油に代わる持続可能で道徳的なものとして藻類由来のオメガ3系に惹かれています。これらのオメガ3は特にDHAを多く含んでいます。藻類は管理された環境で栽培できるため、環境への影響が少なく、一貫性と拡張性があります。さらに、食品、飲料、栄養補助食品市場における植物由来のオメガ3製剤の拡大は、クリーンラベル製品やアレルゲンフリーのサプリメントに対する需要の高まりに支えられています。

高い価格圧力と市場競争

市場は現在、オメガ3の人気の高まりにより、多国籍大企業、栄養補助食品会社、地元サプライヤー、プライベートブランドが混在し、非常に競争が激しくなっています。その結果、基本的なオメガ3製品はコモディティ化し、企業は積極的な価格戦略を採らざるを得なくなっています。そのため、特に中小企業にとっては利益率が圧迫され、低価格で同等の商品を提供する有名ブランドと競争することが難しくなっています。さらに、製品の差別化が難しくなるにつれ、際立った存在になるために、企業はブランディング、イノベーション、認証にさらに投資する必要があります。

COVID-19の影響：

COVID-19の大流行はオメガ3市場に様々な影響を与えましたが、最終的には良い方向に向かいました。サプライチェーンの中断と物流の制限は当初、原材料、特に魚油の入手に影響を与え、生産と流通の遅れを引き起こしました。消費者の優先順位が免疫、予防、健康全般に変わったため、パンデミックの拡大とともに、オメガ3製品などの栄養補助食品の消費は劇的に増加しました。さらに、EPAとDHAが免疫、呼吸器、心臓血管の健康をどのようにサポートするかについての知識が深まったこと、特に消費者への直接販売やeコマースを通じて、消費量の増加に拍車がかかりました。

予測期間中、ドコサヘキサエン酸（DHA）セグメントが最大となる見込み

ドコサヘキサエン酸（DHA）セグメントは、特に妊婦や乳幼児の脳開拓、認知機能、視覚の健康に重要な役割を果たすため、予測期間中に最大の市場シェアを占めると予想されます。DHAは、ベビー用ミルク、妊婦用ビタミン剤、強化食品によく含まれる成分です。また、記憶力を向上させ、神経変性疾患のリスクを低下させることから、高齢者にも重宝されています。さらに、最も顕著で経済的に重要な市場セグメントはDHAであり、その高い臨床検証レベルと神経学的利点に対する消費者の高い認識によるものです。

栄養補助食品分野は予測期間中最も高いCAGRが見込まれる

予測期間中、栄養補助食品分野が最も高い成長率を示すと予測されます。オメガ3系サプリメントの需要は、心臓の健康、認知機能、炎症抑制に対する有益な効果など、オメガ3系の健康上の利点に対する消費者の意識の高まりによって牽引されています。世界人口の高齢化、フィットネスとウェルネスの動向の人気の高まり、予防ヘルスケアへの欲求の高まりは、すべてこの市場を支援しています。さらに、オメガ3栄養補助食品は、グミ、ソフトジェル、カプセルの形で使いやすく便利なため、非常に人気があります。

最大のシェアを占める地域：

予測期間中、北米地域が最大の市場シェアを占めると予想されます。オメガ3の健康効果、特に心臓の健康、認知機能、炎症管理に対する消費者の意識が高いことが、この地域の普及を後押ししています。さらに、北米では医療インフラが整備されているため、オメガ3製品は容易に入手できます。人口の高齢化と予防医療の傾向の高まりは、オメガ3サプリメントの需要をさらに煽り、北米を最大かつ最速で成長する市場にしています。

CAGRが最も高い地域：

予測期間中、アジア太平洋は最も高いCAGRを示すと予測され、中国、インド、日本などの国々では、可処分所得の増加、健康志向の高まり、栄養補助食品需要の高まりがその原動力となっています。同地域では、中産階級の増加や、より健康的な欧米式食生活への移行を含む食生活選好の変化により、オメガ3製品の消費が増加しています。さらに、予防ヘルスケアの重視と心血管疾患などの慢性疾患の増加が、オメガ3系サプリメントの需要を押し上げています。同地域の市場は、eコマースの成長とオメガ3脂肪酸を豊富に含む食品へのアクセスの改善により急速に拡大しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東・アフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、ジョイントベンチャー
買収と合併
新製品発売
事業拡大
その他の主要戦略

第10章企業プロファイリング

BASF SE
Rabar Pty Ltd
Croda International Plc
Omega Protein Corporation
ADM
Lonza Group
Kerry Group Plc
Glanbia Plc
Sinomega Biotech Engineering Co. Ltd.
Cargill, Incorporated
Algisys LLC
Polaris
Koninklijke DSM N.V.
Kinomega Biopharm Inc.
SternVitamin GmbH & Co. KG

図表

List of Tables

Table 1 Global Omega-3 Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Omega-3 Market Outlook, By Type (2024-2032) ($MN)
Table 3 Global Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
Table 4 Global Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
Table 5 Global Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
Table 6 Global Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
Table 7 Global Omega-3 Market Outlook, By Source (2024-2032) ($MN)
Table 8 Global Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
Table 9 Global Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
Table 10 Global Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
Table 11 Global Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
Table 12 Global Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
Table 13 Global Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
Table 14 Global Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
Table 15 Global Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
Table 16 Global Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
Table 17 Global Omega-3 Market Outlook, By Application (2024-2032) ($MN)
Table 18 Global Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
Table 19 Global Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
Table 20 Global Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 21 Global Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
Table 22 Global Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
Table 23 Global Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
Table 24 North America Omega-3 Market Outlook, By Country (2024-2032) ($MN)
Table 25 North America Omega-3 Market Outlook, By Type (2024-2032) ($MN)
Table 26 North America Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
Table 27 North America Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
Table 28 North America Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
Table 29 North America Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
Table 30 North America Omega-3 Market Outlook, By Source (2024-2032) ($MN)
Table 31 North America Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
Table 32 North America Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
Table 33 North America Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
Table 34 North America Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
Table 35 North America Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
Table 36 North America Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
Table 37 North America Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
Table 38 North America Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
Table 39 North America Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
Table 40 North America Omega-3 Market Outlook, By Application (2024-2032) ($MN)
Table 41 North America Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
Table 42 North America Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
Table 43 North America Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 44 North America Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
Table 45 North America Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
Table 46 North America Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
Table 47 Europe Omega-3 Market Outlook, By Country (2024-2032) ($MN)
Table 48 Europe Omega-3 Market Outlook, By Type (2024-2032) ($MN)
Table 49 Europe Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
Table 50 Europe Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
Table 51 Europe Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
Table 52 Europe Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
Table 53 Europe Omega-3 Market Outlook, By Source (2024-2032) ($MN)
Table 54 Europe Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
Table 55 Europe Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
Table 56 Europe Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
Table 57 Europe Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
Table 58 Europe Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
Table 59 Europe Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
Table 60 Europe Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
Table 61 Europe Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
Table 62 Europe Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
Table 63 Europe Omega-3 Market Outlook, By Application (2024-2032) ($MN)
Table 64 Europe Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
Table 65 Europe Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
Table 66 Europe Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 67 Europe Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
Table 68 Europe Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
Table 69 Europe Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
Table 70 Asia Pacific Omega-3 Market Outlook, By Country (2024-2032) ($MN)
Table 71 Asia Pacific Omega-3 Market Outlook, By Type (2024-2032) ($MN)
Table 72 Asia Pacific Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
Table 73 Asia Pacific Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
Table 74 Asia Pacific Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
Table 75 Asia Pacific Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
Table 76 Asia Pacific Omega-3 Market Outlook, By Source (2024-2032) ($MN)
Table 77 Asia Pacific Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
Table 78 Asia Pacific Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
Table 79 Asia Pacific Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
Table 80 Asia Pacific Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
Table 81 Asia Pacific Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
Table 82 Asia Pacific Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
Table 83 Asia Pacific Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
Table 84 Asia Pacific Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
Table 85 Asia Pacific Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
Table 86 Asia Pacific Omega-3 Market Outlook, By Application (2024-2032) ($MN)
Table 87 Asia Pacific Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
Table 88 Asia Pacific Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
Table 89 Asia Pacific Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 90 Asia Pacific Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
Table 91 Asia Pacific Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
Table 92 Asia Pacific Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
Table 93 South America Omega-3 Market Outlook, By Country (2024-2032) ($MN)
Table 94 South America Omega-3 Market Outlook, By Type (2024-2032) ($MN)
Table 95 South America Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
Table 96 South America Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
Table 97 South America Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
Table 98 South America Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
Table 99 South America Omega-3 Market Outlook, By Source (2024-2032) ($MN)
Table 100 South America Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
Table 101 South America Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
Table 102 South America Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
Table 103 South America Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
Table 104 South America Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
Table 105 South America Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
Table 106 South America Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
Table 107 South America Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
Table 108 South America Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
Table 109 South America Omega-3 Market Outlook, By Application (2024-2032) ($MN)
Table 110 South America Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
Table 111 South America Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
Table 112 South America Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 113 South America Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
Table 114 South America Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
Table 115 South America Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
Table 116 Middle East & Africa Omega-3 Market Outlook, By Country (2024-2032) ($MN)
Table 117 Middle East & Africa Omega-3 Market Outlook, By Type (2024-2032) ($MN)
Table 118 Middle East & Africa Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
Table 119 Middle East & Africa Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
Table 120 Middle East & Africa Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
Table 121 Middle East & Africa Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
Table 122 Middle East & Africa Omega-3 Market Outlook, By Source (2024-2032) ($MN)
Table 123 Middle East & Africa Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
Table 124 Middle East & Africa Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
Table 125 Middle East & Africa Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
Table 126 Middle East & Africa Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
Table 127 Middle East & Africa Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
Table 128 Middle East & Africa Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
Table 129 Middle East & Africa Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
Table 130 Middle East & Africa Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
Table 131 Middle East & Africa Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
Table 132 Middle East & Africa Omega-3 Market Outlook, By Application (2024-2032) ($MN)
Table 133 Middle East & Africa Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
Table 134 Middle East & Africa Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
Table 135 Middle East & Africa Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
Table 136 Middle East & Africa Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
Table 137 Middle East & Africa Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
Table 138 Middle East & Africa Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)

Product Code: SMRC29527

According to Stratistics MRC, the Global Omega-3 Market is accounted for $10.76 billion in 2025 and is expected to reach $31.72 billion by 2032 growing at a CAGR of 16.7% during the forecast period. Omega-3 fatty acids are essential nutrients that support numerous bodily functions, with well-documented benefits for heart, brain, and eye health. Plant sources like flaxseeds and walnuts, as well as fatty fish like salmon and mackerel, are common sources of these polyunsaturated fats. Regular consumption of omega-3 fatty acids is required because the human body is unable to synthesize them effectively. Moreover, studies have demonstrated that omega-3 fatty acids support cardiovascular health, enhance cognitive function, reduce inflammation, and may even reduce the risk of chronic conditions like arthritis and heart disease.

According to the American Heart Association (AHA), omega-3 fatty acids play a significant role in cardiovascular health. The AHA recommends that adults consume at least two servings of fatty fish per week, such as salmon, mackerel, or sardines, to obtain these beneficial nutrients. For individuals with elevated triglyceride levels, the AHA advises a daily intake of 2 to 4 grams of EPA and DHA combined, under medical supervision, to effectively lower triglycerides by 20% to 40%.

Market Dynamics:

Driver:

Increasing knowledge of health

Omega-3 fatty acids, particularly EPA and DHA, have been thoroughly studied for their role in supporting heart health, reducing inflammation, aiding brain development, and improving vision. Public health campaigns and endorsements from medical organizations like the American Heart Association have further solidified the role of omega-3s in maintaining long-term wellness. As consumers around the world become more health-conscious, there is an increasing demand for preventive healthcare and nutritional solutions. Additionally, this shift toward proactive health management is propelling people to incorporate omega-3 supplements or enriched foods into their daily routine.

Restraint:

High production and final product costs

High-quality omega-3 fatty acid extraction, purification, and stabilization-particularly EPA and DHA-from marine sources are expensive procedures. Supercritical CO2 extraction and molecular distillation are two efficient but costly technologies. Fish from regulated fisheries or algae grown in controlled conditions also raise the cost of production. Omega-3-enriched products and supplements are relatively expensive when compared to other nutritional alternatives because these costs are frequently passed on to consumers. Furthermore, the penetration of the mass market may be restricted by this high price point, especially in developing nations where consumers are price sensitive.

Opportunity:

Growing need for omega-3s derived from plants and algae

Demand for non-animal omega-3 sources is rising as veganism and plant-based diets continue to gain popularity around the world. Vegetarians, vegans, and consumers who care about the environment are drawn to algae-derived omega-3s because they provide a sustainable and moral substitute for fish oil. These omega-3s are especially high in DHA. Because algae can be grown in controlled settings, there is less of an impact on the environment and consistency and scalability. Moreover, the expansion of plant-based omega-3 formulations in the food, beverage, and nutraceutical markets is further supported by the growing demand for clean-label products and allergen-free supplements.

Threat:

High levels of price pressure and market competition

The market is now very competitive, with a mix of big multinational corporations, nutraceutical firms, local suppliers, and private-label brands due to the increasing popularity of omega-3s. As a result, basic omega-3 products have become commoditized, forcing businesses to adopt aggressive pricing strategies. Profit margins are therefore under pressure, particularly for smaller businesses that find it difficult to compete with well-known brands that provide comparable goods at lower prices. Furthermore, in order to stand out, businesses must invest more in branding, innovation, and certifications as product differentiation becomes more challenging.

Covid-19 Impact:

The COVID-19 pandemic affected the Omega-3 market in a variety of ways, but ultimately for the better. Supply chain interruptions and logistical limitations initially impacted raw material availability, especially fish oil, and caused production and distribution delays. Consumption of dietary supplements, such as Omega-3 products, increased dramatically as the pandemic spread because consumers' priorities changed to immunity, preventive health, and general wellness. Moreover, higher consumption was fuelled by greater knowledge of how EPA and DHA support immune, respiratory, and cardiovascular health, especially through direct-to-consumer and e-commerce channels.

The docosahexaenoic acid (DHA) segment is expected to be the largest during the forecast period

The docosahexaenoic acid (DHA) segment is expected to account for the largest market share during the forecast period because of the vital role it plays in brain development, cognitive function, and visual health, especially in pregnant women and infants. DHA is a common ingredient in baby formulas, prenatal vitamins, and fortified foods. It is also valued in the elderly population for its ability to improve memory and lower the risk of neurodegenerative diseases. Additionally, the most prominent and economically significant market segment is DHA due to its high level of clinical validation and high consumer awareness of its neurological benefits.

The dietary supplements segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dietary supplements segment is predicted to witness the highest growth rate. The demand for Omega-3 supplements has been driven by rising consumer awareness of the health advantages of Omega-3, such as its beneficial effects on heart health, cognitive function, and inflammation reduction. The aging of the world's population, the growing popularity of fitness and wellness trends, and the growing desire for preventative healthcare all help this market. Furthermore, Omega-3 dietary supplements are very popular due to their ease of use and convenience in the form of gummies, soft gels, and capsules.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The high level of consumer awareness of Omega-3's health benefits-particularly for heart health, cognitive function, and inflammation management-fuels this region's prevalence. Moreover, Omega-3 products are easily accessible due to the established healthcare infrastructure in North America. The aging of the population and the growing trend of preventive healthcare further fuel demand for Omega-3 supplements, making North America the region with the biggest and fastest-growing market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven in nations like China, India, and Japan by rising disposable incomes, growing health consciousness, and growing demand for dietary supplements. Omega-3 product consumption is rising in the region due to the growing middle class and shifting dietary preferences, including a move toward healthier, Western-style diets. Additionally, the growing emphasis on preventive healthcare and the rise of chronic diseases such as cardiovascular conditions are propelling the demand for Omega-3 supplements. The region's market is expanding quickly due in large part to the growth of e-commerce and improved access to foods enriched with omega-3 fatty acids.

Key players in the market

Some of the key players in Omega-3 Market include BASF SE, Rabar Pty Ltd, Croda International Plc, Omega Protein Corporation, ADM, Lonza Group, Kerry Group Plc, Glanbia Plc, Sinomega Biotech Engineering Co. Ltd., Cargill, Incorporated, Algisys LLC, Polaris, Koninklijke DSM N.V., Kinomega Biopharm Inc. and SternVitamin GmbH & Co. KG.

Key Developments:

In March 2025, ADM and Mitsubishi Corporation have signed an agreement. This agreement is a non-binding memorandum of understanding. The companies will form a strategic alliance. They will explore potential areas for future collaboration. This collaboration will span the agriculture value chain. The importance of secure food supply chains has increased recently.

In October 2024, BASF, AM Green ink MoU for low-carbon chemical production in India. The agreement was signed by Dr. Markus Kamieth, Chairman of the Board of Executive Directors of BASF SE, and Mahesh Kolli, Group President of AM Green, during the Asia-Pacific Conference of German Business 2024 held in New Delhi.

In March 2024, Croda International has entered a collaboration agreement with the Access to Advanced Health Institute (AAHI) to innovate and develop vaccine adjuvant formulations. Under this deal, the parties will use their combined capabilities to make new vaccine adjuvants accessible worldwide. This approach will aid in the advancement of next-generation vaccines that are robust and durable.

Types Covered:

Docosahexaenoic Acid (DHA)
Eicosapentaenoic Acid (EPA)
Alpha-linolenic Acid (ALA)
Other Types

Sources Covered:

Marine Source
Plant Source
Other Sources

Applications Covered:

Dietary Supplements
Pharmaceuticals
Infant Formula
Animal Feed & Pet Food
Food & Beverages/Functional Foods
Other Applications

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Omega-3 Market, By Type

5.1 Introduction
5.2 Docosahexaenoic Acid (DHA)
5.3 Eicosapentaenoic Acid (EPA)
5.4 Alpha-linolenic Acid (ALA)
5.5 Other Types

6 Global Omega-3 Market, By Source

6.1 Introduction
6.2 Marine Source
- 6.2.1 Fish Oil
- 6.2.2 Algal Oil
- 6.2.3 Krill Oil
6.3 Plant Source
- 6.3.1 Nuts & Seeds
- 6.3.2 Vegetable Oils
- 6.3.3 Soy & Soya Products
6.4 Other Sources

7 Global Omega-3 Market, By Application

7.1 Introduction
7.2 Dietary Supplements
7.3 Pharmaceuticals
7.4 Infant Formula
7.5 Animal Feed & Pet Food
7.6 Food & Beverages/Functional Foods
7.7 Other Applications

8 Global Omega-3 Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 BASF SE
10.2 Rabar Pty Ltd
10.3 Croda International Plc
10.4 Omega Protein Corporation
10.5 ADM
10.6 Lonza Group
10.7 Kerry Group Plc
10.8 Glanbia Plc
10.9 Sinomega Biotech Engineering Co. Ltd.
10.10 Cargill, Incorporated
10.11 Algisys LLC
10.12 Polaris
10.13 Koninklijke DSM N.V.
10.14 Kinomega Biopharm Inc.
10.15 SternVitamin GmbH & Co. KG

オメガ3市場の2032年までの予測：タイプ別、ソース別、用途別、地域別の世界分析

Omega-3 Market Forecasts to 2032 - Global Analysis By Type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), Alpha-linolenic Acid (ALA) and Other Types), Source (Marine Source, Plant Source and Other Sources), Application and By Geography

COVID-19の影響：

最大のシェアを占める地域：

CAGRが最も高い地域：

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界のオメガ3市場：タイプ別

第6章 世界のオメガ3市場：ソース別

第7章 世界のオメガ3市場：用途別

第8章 世界のオメガ3市場：地域別

第9章 主な発展

第10章 企業プロファイリング